Standard Biotools Inc. · NASDAQ:LAB
Eli Casdin reported a 21.60% stake in Standard Biotools Inc. (Schedule 13D/A)
Event Feb 28, 2025 · Filed Mar 4, 2025
Eli Casdin reported a 21.60% stake in Standard Biotools Inc., 80,864,315 shares, with active intent on Feb 28, 2025. Filed Mar 4, 2025 (Schedule 13D/A).
- Stake
- 21.60%
- Shares
- 80,864,315
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Casdin Capital, LLC | 20.40% | 76,075,636 |
| Casdin Private Growth Equity Fund II, L.P. | 3.70% | 13,939,637 |
| Casdin Private Growth Equity Fund II GP, LLC | 3.70% | 13,939,637 |
| Casdin Partners Master Fund, L.P. | 15.90% | 59,391,780 |
| Casdin Partners GP, LLC | 15.90% | 59,391,780 |
| Eli Casdin | 21.60% | 80,864,315 |
Source
Related
- Standard Biotools Inc.
- Casdin Eli
- Standard Biotools Inc. shareholders
- Schedule 13D/A · Casdin Eli · Jun 9, 2026
- Schedule 13D/A · Casdin Eli · Nov 28, 2025
- Form 4 · Mackay Sean · Aug 24, 2026
- Form 4 · Kim Hanjoon Alex · Aug 24, 2026
- Form 4 · Egholm Michael · Aug 24, 2026
- Schedule 13G · Long Focus Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Mak Capital One LLC · Aug 14, 2026